In a rare move, maker of failed ALS drug removes it from the market
Washington Post
Amylyx Pharmaceuticals said it would voluntarily remove its FDA-approved drug for amyotrophic lateral sclerosis from the market after a trial showed it doesn’t work.
https://www.washingtonpost.com/business/2024/04/04/amylyx-als-drug/